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Abstract
Background: Cervical cancer is the fourth cause of death worldwide by cancer in women and is a disease
associated to persistent infection with human papillomavirus (HPV), particularly from two high-risk types HPV16
and 18. The virus initiates its replicative cycle infecting cells located in the basal layer of the epithelium, where a
small population of epithelial stem cells is located performing important functions of renewal and maintenance
of the tissue. Viral E2 gene is one of the first expressed after infection and plays relevant roles in the replicative
cycle of the virus, modifying fundamental processes in the infected cells. Thus, the aim of the present study was
to demonstrate the presence of hierarchic subpopulations in HaCaT cell line and evaluate the effect of HPV16-E2
expression, on their biological processes.
Methods: HaCaT-HPV16-E2 cells were generated by transduction of HaCaT cell line with a lentiviral vector. The
α6-integrin-CD71 expression profile was established by immunostaining and flow cytometric analysis. After sorting,
cell subpopulations were analyzed in biological assays for self-renewal, clonogenicity and expression of stemness
factors (RT-qPCR).
Results: We identified in HaCaT cell line three different subpopulations that correspond to early differentiated
cells (α6-integrindim), transitory amplifying cells (α6-integrinbri/CD71bri) and progenitor cells (α6-integrinbri/CD71dim).
The last subpopulation showed stem cell characteristics, such as self-renewal ability, clonogenicity and expression
of the well-known stem cell factors SOX2, OCT4 and NANOG, suggesting they are stem-like cells. Interestingly, the
expression of HPV16-E2 in HaCaT cells changed its α6-integrin-CD71 immunophenotype modifying the relative
abundance of the cell subpopulations, reducing significantly the percentage of α6-integrinbri/CD71dim cells.
Moreover, the expression of the stem cell markers was also modified, increasing the expression of SOX2 and
NANOG, but decreasing notably the expression of OCT4.
Conclusions: Our data demonstrated the presence of a small subpopulation with epithelial “progenitor cells”
characteristics in the HaCaT cell line, and that HPV16-E2 expression on these cells induces early differentiation.
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Background
High risk papillomavirus (HPV16 and 18) have been
widely studied due to its association with cervical cancer
and tumors of other anogenital sites [1]. These are small
un-envolved virus with a circularized double stranded
DNA genome, containing eight open reading frames that
are expressed either early (E1, E2, E4, E5, E6 and E7) or
late (L1 and L2) during the infection, and a noncoding
region known as long control region (LCR) which con-
tains the viral early promoter, the enhancer and the origin
of replication [2, 3].
The HPV life cycle is intimately linked to epithelial
differentiation [1]. HPV normally infects dividing cells at
the basal layer of the epithelium but completes its life
cycle by amplifying progeny DNA genomes in the spinous
layer and carrying out viral encapsidation in the upper-
most epithelial layer named the granular layer [4].
One of the proteins that plays a crucial role in the
papillomaviruses life cycle is the E2 protein. It pos-
sesses a DNA-binding domain and a transactivation
domain that are linked by a serine-arginine-rich hinge
region [5]. E2 as a homodimer binds the cognate se-
quences ACCGN4CGGT (E2-binding sites [E2BSs]) in
the viral LCR, and different experimental systems have
shown that it regulates the viral E6 and E7 oncogenes
transcription, acting as an activator or as a repressor
depending on the protein levels and the specific sites
contacted [6, 7]. However, the evidence points to a re-
pressive function of E2 in controlling the viral early
promoter [8]. On the other hand, another important
role of E2 is to participate as an auxiliary replication
factor, since at the origin of DNA replication, E2 inter-
acts with and loads the HPV E1 replication helicase,
recruiting then the cellular DNA replication machinery
[8–11]. E2 also has an crucial role in segregation of
viral episomal genomes during the division of infected
cells by interacting with chromatin adapter proteins
that tether them to host mitotic chromosomes [8].
In addition, possibly by an indirect mechanism involving
its interaction with several cellular proteins, the expres-
sion of E2 also has an impact on the cellular transcription
profile, affecting the expression of genes involved in key
processes such as proliferation, differentiation, apoptosis
and senescence [12–20].
The biological effects of E2 on mammalian cells have
been generally studied using transiently transfected cancer
cell lines. Early studies in HPV-positive cervical carcinoma
derived cell lines [21], indicated that transient overexpres-
sion of E2 induces apoptosis in these cells due to repres-
sion of endogenous E6/E7 expression [22–27]. However,
also in HPV negative cells, E2 overexpression induces
apoptosis by both transactivation independent and medi-
ated through activation of caspase 8 [28, 29]. It has been
also observed that sustained expression of E2 in HPV
positive cells, induces a prolonged growth arrest and
induces irreversible senescence [30–33], probably as a
default pathway for cells which exit the cell cycle, since
most of these cells are incapable of terminal differentiation.
Then, the observed effects of E2 on the processes of
apoptosis and senescence could be related to its role in
differentiation, since it is well known that a critical step
to start this process is an arrest in the cell cycle followed
by the expression of genes involved in early differenti-
ation. If these genes are not correctly expressed, cells
could keep in an irreversible senescence status and
progress later to apoptosis or immortalization programs
[34, 35].
Considering the technical difficulty to establish a con-
venient cellular stratification system to follow step by step
the progress of the infection, most of the studies on the ef-
fects of HPV gene expression on epithelial differentiation
process have been performed on carcinoma derived cell
lines [36–38], or immortalized keratinocytes from several
tissues [39–41].
In fact, the induction of cell differentiation has
been demonstrated in HPV16-E2 stably transfected
HaCaT cells, showing a typical differentiated morph-
ology, cell elongation and multilayer colonies growth,
besides the expression of the classical keratinocytes
differentiation markers involucrin, filagrin and cyto-
keratins 1 and 10 [34].
However, since E2 is one of the first expressed genes
in the epithelial basal layer during infection [42, 43], the
understanding of its effects on early differentiation must
be studied on cellular models that mimic this layer in
the epithelium, considering the cellular subpopulations
that constitute it, including epithelial stem cells.
Different strategies have been used to identify these
cells from epithelial derived transformed cell lines and
keratinocytes primary cultures, such as the expression
of the membrane molecules desmoglein-3 and β1-
integrin, the nuclear presence of p63, or metabolic charac-
teristics of these cells, such as the over-expression of
aldehyde-dehydrogenase enzyme (ALDH) or the ATP-
binding cassette subfamily G (ABCG) transporter pump
[44–47]. Nevertheless, the simultaneous detection of α6-
integrin (CD49f) and the transferrin receptor CD71 levels
has demonstrated in a very confident form a hierarchical
organization in keratinocytes primary cultures with the
presence of three cellular subpopulations [48].
In the present work, we have taken advantage of the α6-
integrin and CD71 detection and cell separation described
by Schluter et al. [48], and demonstrated that HaCaT cell
line derived from spontaneously immortalized keratino-
cytes, where HPV genomes are absent and have been
extensively used to simulate epithelial tissues, possess cellu-
lar subpopulations with similar characteristics to those
from the stratified epithelial basal layer, corresponding to:
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cells in an early differentiation process α6-integrindim
(8.16 ± 0.52%), transitory amplifying cells α6-integrinbri/
CD71bri (87.27 ± 1.21%) and progenitor cells α6-
integrinbri/CD71dim (1.16 ± 0.08%) . This latter subpopula-
tion expressed high mRNA levels of SOX2, NANOG and
OCT4 factors, a high self-renewal activity and a high pro-
portion of holoclones formation in clonogenic assays, all
of them characteristics of epithelial stem cells.
Besides, we demonstrated that HPV16-E2 expression
modifies the relative abundance of these subpopulations,
favoring the enrichment of the early differentiated sub-
population in a comparable way than the differentiation
processes produced by the induction with retinoic acid
(RA) or calcium chloride (CaCl2) in these cells.
Methods
Cell cultures
HEK293-FT cells from ATCC and HaCaTcells (a generous
gift from Dr. Norbert Fusenig) were grown in culture
dishes in Dulbecco’s modified Eagle’s medium (DMEM,
Invitrogen, CA, USA) supplemented with 10% fetal bovine
serum (FBS, Gibco, NY, USA), L-glutamine (2 mM),
sodium pyruvate (1 mM), penicillin (50 U/ml), and
streptomycin (50 μg/ml). Both cell lines were incubated in
a humidified atmosphere with 5% CO2 at 37 °C and main-
tained in exponential growth phase.
Lentiviral generation
A lentiviral system containing a cassette for puromycin
selection and the transgene expression controlled by
the promoter for the elongation factor 1-α (EF1-α), was
used in this work. The E2 gene from HPV16 was ampli-
fied by PCR with the forward (Fw) primer 5′ ATTCCG
AATTCATGGAGACTCT 3′ and the reverse (Rev)
primer 5′ TTCGGGATCCTCATATAGACAT 3′, using
as a template the plasmid pcDNA3-E2. The correspond-
ing amplicon was cloned in the pSin-EF2-Pur plasmid
(Addgene, MA, USA) using the EcoRI and BamHI restric-
tion sites, generating the vector pSin-EF2-E216-Pur. A
pSin-EF2-Vac-Pur vector was also built, incorporating the
EcoRI-BamHI fragment from the pSin-EF2-Pur plasmid.
This vector pSin-EF2-Vac-Pur allowed us to generate a
lentivirus that does not contain expression cassette,
denominated Lenti-Vac. Lentivirus were generated by co-
transfection of the corresponding pSin-EF2-X-Pur with
pMD2.G and psPAX2 plasmids into packing HEK293-
FT cells using Lipofectamine Transfection Reagent
(Invitrogen, CA, USA) during 24 h. After 48 h transfec-
tion, the supernatant from the cell cultures were
ultracentrifugated (25,000 rpm in SW41 Ti rotor) for 2
h at 4 °C, to purify the lentiviral particles. The pellets
were suspended in cold phosphate buffer saline (PBS)
containing 0.01% bovine serum albumin (BSA) and
stored at -70 °C.
Lentiviral transduction
2.5 × 105 HaCaT cells were seeded in DMEM with 10%
SFB 24 h before the infection. The cell cultures were
then incubated with 1 MOI (multiplicity of infection) of
either HPV16-E2 lentivirus or Lenti-Vac for 24 h in
DMEM with 10% SFB and polybrene (8 μg/ml), in order
to allow virus adsorption. The viral stock was then re-
moved away and 48 h post-infection the puromycin
(Sigma-Aldrich, MO, USA) selection (0.45 μg/ml) was
started.
RNA extraction and gene expression analysis
Total RNA was extracted from cells using the TRIzol
method, treated with RQ1 DNase (Promega, WI, USA) for
2 h at 37 oC and 2 μg of RNA were reverse transcribed
into cDNA using the enzyme M-MLV RT at 42 °C and
Oligo-dT15 (Promega, WI, USA).
To determinate the transduction and the transgene
expression, we amplify by PCR a 250 bp fragment of
the HPV16-E2 gene, using primers Fw: 5′ TTGGGG
ATCCGTGTTTAGCAGCAACGAAGTAT 3′ and Rev:
5′ ATCCGAATTCTCAGTTAATCCGTCCTTTGTGT
GAGCT 3′. HPV16-E2 expression in transduced cells
was monitored daily.
To evaluate the mRNA expression of the stem cells
markers we performed Real-Time PCR (qPCR) using the
ABsolute qPCR SYBR Green Mix (Thermo Scientific,
PA, USA) and an ABI StepOnePlus Real-Time PCR
System, using the following primers: SOX2 Fw: 5′ TCA
GGAGTTGTCAAGGCAGAG 3′, Rev: 5′ AGAGGCAA
ACTGGAATCAGGA 3′; NANOG Fw: 5′ GCAATGGT
GTGACGCAGAAG 3′, Rev: 5′ ATTGGAAGGTTCCC
AGTCGG 3′; OCT4 Fw: 5′ CTTCGCAAGCCCTCA
TTTCACC 3′, Rev: 5′ GGTCCGAGGATCAACCCAG
3′. As a control for endogenous constitutively expressed
gene, we used β-actin Fw: 5′ GCGGGAAATCGTGCGT
GACATT 3′, Rev: 5′ GATGGAGTTGAAGGTAGTTT
CGTG 3′. Relative quantification values and the cycle
thresholds (Cts) for the target amplicon and the endogen-
ous control (β-actin) were determined for each sample
(Total, α6-integrinbri/CD71dim and Non-α6-integrinbri/
CD71dim). The value for the target, normalized to the
endogenous control for the samples, relative to the
value in the total cells was then calculated with the for-
mula ΔΔCt [49].
Immunoblotting analysis of proteins
Total cell lysates were prepared from HaCaT wild type
(HaCaTwt) and HaCaT-HPV16-E2 using Bolen-modified
RIPA buffer (20 mM MOPS-NaOH pH 7.0, 150 mM
NaCl, 1% sodium deoxycholate, 1% Nonidet P-40, 1 mM
EDTA, 0.1% SDS) and protease inhibitor cocktail (Roche
Diagnostics, Basel, Switzerland). Total proteins (50 μg)
were separated through SDS 10% polyacrilamide gels
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(SDS-PAGE), transferred to nitrocellulose membranes,
and immunoblotted using either specific anti-HPV16-E2,
anti-cytokeratin 14 (Santa Cruz Biotecnology Inc., CA,
USA), anti-cytokeratin 10 (Abcam PLC, MA, USA) or
anti-β-actin (a generous gift of Dr. Manuel Hernández)
monoclonal antibodies. Secondary antibodies peroxidase
conjugated AffiniPure goat anti-mouse IgG (H + L) or
peroxidase conjugated AffiniPure goat anti-rabbit IgG
(H + L) (Jackson ImmunoResearch Laboratories, PA,
USA) were used. Immunoreaction was developed using
the SuperSignal West Pico Chemiluminiscent Substrate
(Thermo Scientific, IL, USA) and the proteins were
quantified with Image J software (National Institutes of
Health, MD, USA).
Flow - cytometric analysis and cell sorting
HaCaT cell cultures (lentivirus transduced or wt) were
washed twice in PBS, trypsinized, and suspended in ice-
cold PBS containing 2% FBS/2% BSA and kept for
15 min at 4 °C. Cells were pelleted by centrifugation
and suspended at 1 × 106/100 μl in ice-cold PBS con-
taining 1% BSA and then processed for single or double
staining with PE-Cy5 mouse anti-human CD71 and PE
rat anti-human α6 integrin (BD Biosciences, NJ, USA)
during 45 min at 4 °C, using the appropriate negative
controls to establish the compensation settings on the
FACS. Cells were washed twice with cold PBS, sus-
pended in PBS at 2–3 × 106/ml, and kept at 4 °C until
their flow-cytometric analysis. Cell sorting was per-




HaCaTwt cells sorted after α6-integrin-CD71 staining,
were seeded in six-wells plates at 4.5 × 103 cells/well
and cultured under standard conditions. After 10 days
culture, cells were analyzed for cell surface phenotype
(α6-integrinbri/CD71dim and Non-α6-integrinbri/CD71dim)
and sorted at subsequent passage for another cycle of
10 days to evaluate the self-renewal capacity.
Colony heterogeneity assay
α6-integrinbri/CD71dim and Non-α6-integrinbri/CD71dim
HaCaTwt cells sorted after α6-integrin-CD71 staining,
were seeded in six-wells plates at 4.5 × 103 cells/well and
cultured under standard conditions. After 7 days culture,
the morphology of the clones (classified as holoclones
and paraclones) was observed and counted under an
inverted light microscope evaluating the percentage of
each type of clone.
Differentiation analysis
HaCaTwt cells were seeded and cultured under standard
conditions during 24 h. The cell cultures were then washed
twice with PBS and incubated with complete media
containing CaCl2 5 mM or RA 1 μM (Sigma-Aldrich, MO,
USA) during additional 5 days. Then cells were harvested
and lysates prepared for the analysis of epithelial differenti-
ation markers.
HaCaTwt and HaCaT-HPV16-E2 were treated with
CaCl2 or RA as above indicated. After that, the cells
were harvested and analyzed by flow cytometry for the
α6-integrin-CD71 cell surface phenotype, in order to
compare the differentiation status in HaCaTwt and
HaCaT-HPV16-E2.
Statistical analysis
Data were analyzed using GraphPad Prism® v6.0 (GraphPad
Software). Results represent the mean of at least three inde-
pendent experiments; bar ± standard deviation (SD). An
ANOVA test was used to determine the statistical signifi-
cance of differences in values between two groups. Statis-
tical significance was defined as p value <0.05.
Results
Identification of a “stem-like” subpopulation in HaCaT cell
line
To demonstrate the presence of a “progenitor” subpopula-
tion in HaCaT cell line, we analyzed the cells using the
technique described for Schluter et al. [48]. Representative
results from the flow-cytometric analyses are shown in
Fig. 1 panel a. The HaCaT cell line in our culture condi-
tions presented a profile of three subpopulations with dif-
ferent immunophenothypes: α6-integrindim (8.16 ± 0.52%)
(R8) that correspond to “early differentiated cells”, α6-
integrinbri/CD71bri (87.27 ± 1.21%) (R7) corresponding to
“transitory amplifying cells” and α6-integrinbri/CD71dim as
a minor subpopulation (1.16 ± 0.08%) (R6) apparently
corresponding to “progenitor” cells. To corroborate the
biological characteristics of these cellular subpopulations,
we performed a self-renewal assay sorting the cells after
anti-α6-integrin-CD71 staining by flow cytometry and
reseeding in separated wells cells from the α6-integrinbri/
CD71dim subpopulation and a mix of cells from the α6-
integrinbri/CD71bri and α6-integrindim subpopulations
(Non-α6-integrinbri/CD71dim), and evaluated their cap-
acity to regenerate the normal immunophenotypes of the
cultures, enrichment ability and colony morphology in
clonogenic assays.
α6-integrinbri/CD71dim restored the immunophenotype
of the total cell population in each cycle of sorting and
reseeding, and after two rounds the percentage of this sub-
population increased from 2.8 ± 0.54% to 3.9 ± 0.33% (Fig. 1,
panels a and b). The reseeding of the Non-α6-integrinbri/
CD71dim was unable to restore the immunophenotype of
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the total population, generating only Non-α6-integrinbri/
CD71dim (Fig. 1 panel a and Additional file 1: Table S1).
Moreover, in the clonogenic assay the percentage of
holoclones derived from the α6-integrinbri/CD71dim
after sorting and reseeding was considerably higher than
those with paraclone morphology in both enrichment as-
says (62 ± 2% vs 38 ± 3.5% and 68 ± 5.5% vs 32 ± 3.5%)
(Fig. 1, panel c), while as expected for more differenti-
ated cells, the clone morphology observed after reseeding
the Non-α6-integrinbri/CD71dim, was mostly paraclones
(2% vs 98 ± 1% and 0% vs 100%). Finally, the mRNA evalu-
ation of three of the most important stemness factors
(SOX2, NANOG and OCT4) in the different subpopu-
lations isolated by sorting after anti-α6-integrin-CD71
staining and flow-cytometry (Fig. 1, panels d and e),
indicated that these genes are expressed in high levels
in the α6-integrinbri/CD71dim subpopulation but not
in Non-α6-integrinbri/CD71dim. These results demonstrate
that HaCaT cell line contains a small “progenitor” cell
subpopulation.
Fig. 1 HaCaT cell line possesses a “progenitor” sub-population. a Flow cytometric analyses for α6-integrin and CD71 expression in HaCaT cell
line exhibited three phenotypes: α6-integrindim (R8), α6-integrinbri/CD71bri (R7) and α6-integrinbri/CD71dim (R6). Upper panels correspond to
enrichment assays sorting and reseeding only cells from the α6-integrinbri/CD71dim subpopulation. Lower panels correspond to enrichment
assays sorting and reseeding cells from a mix of α6-integrindim (R8) and α6-integrinbri/CD71bri (R7) subpopulations. b Bars graph of two rounds
enrichment of the α6-integrinbri/CD71dim subpopulation in self-renewal assays. Bars represent the mean ± SD of three independent assays
(p < 0.05). c Bars graph of the clonogenic assays from the α6-integrinbri/CD71dim subpopulation seeded after each round of enrichment.
Bars represent the mean ± SD of three independent assays (p < 0.05). d RT-PCR analyses for the expression of stem cell markers (SOX2, OCT4
and NANOG) in α6-integrinbri/CD71dim subpopulation, Non-α6-integrinbri/CD71dim subpopulation and total population in HaCaT cell line.
e RT-qPCR analyses for the expression of SOX2, OCT4 and NANOG in total HaCaTwt cells and after sorting in α6-integrinbri/CD71dim and
Non-α6-integrinbri/CD71dim subpopulations. Values are expressed as the difference in ΔΔCt and expression of a housekeeping gene (β-actin).
Relative expression of three separated assays expressed as the mean ± SD, p < 0.05, is presented. All images shown are representative of at
least three independent experiments
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HPV16-E2 protein modifies α6-integrin-CD71
immunophenotype in HaCaT cell line
It has been shown that HPV-E2 protein can modulate
several cellular processes, including apoptosis, prolifera-
tion and cell differentiation. In order to evaluate the effect
of the expression of this viral protein on α6-integrin-
CD71 phenotype of HaCaT cell line, we used a lentiviral
vector that efficiently transduce cells from epithelial
origin, but also possess the EF1-α promoter that results in
a high level of transcription of the incorporated transgene,
even in quiescent cells. After transduction of HaCaT cell
line cultures, with Lenti-HPV16-E2 or Lenti-Vac, we
confirmed the expression of the transgene in the
correspondent cultures HaCaT-HPV16-E2 and HaCaT-
Vac 5 days post-infection, obtaining mRNA and analyzing
by RT-PCR (Fig. 2, panel a). Additionally, we obtained
total protein extracts and determined the presence of
HPV16-E2 protein by SDS-PAGE and western blot, using
commercial antibodies (Fig. 2, panel b). As expected,
HPV16-E2 mRNA and protein was only detected in the
HaCaT-HPV16-E2 transduced cell lines.
The flow-cytometric analysis for immunophenotype of
α6-integrin and CD71 staining of the transduced HaCaT
cultures (Fig. 2, panel c) showed evident changes in the
relative abundance of the three subpopulations that con-
stitutes this cell line, when HPV16-E2 is expressed. We
observed a clear increase in the early differentiated cells
(α6-integrindim) passing from 8.16 ± 0.52% to 54 ± 1.34%,
while the stem-like subpopulation (α6-integrinbri/CD71dim)
decreased from 1.16 ± 0.08% to 0.55 ± 0.06%, suggesting
that the expression of this viral gene stimulates the
early differentiation in HaCaT cell line. To discriminate
a possible effect of the lentiviral vector on the α6-integrin-
CD71 phenotype in this cell line, we also compared this
phenotype of Lenti-Vac infected cells against that one
from non-infected cells, observing that infection with this
control virus does not change the subpopulations profile
of HaCaT cell line.
HPV16-E2 protein modifies the expression of “stemness”
factors in HaCaT cell line
Considering the clear reduction (almost 50%) in the
relative abundance of the α6-integrinbri/CD71dim sub-
population in the HaCaT cell line induced by HPV16-
E2 expression, we evaluated the effect of the expression
of this viral protein on the mRNA level of several key
stemness factors. HaCaT cells were either transduced
with Lenti-HPV16-E2 or Lenti-Vac, after 5 days were
stained with anti-α6 integrin-CD71 antibodies and iso-
lated by flow-cytometric sorting the α6-integrinbri/
CD71dim and Non-α6-integrinbri/CD71dim subpopulations
from HaCaT-HPV16-E2, HaCaT-Vac and HaCaTwt.
mRNA from each subpopulation was obtained and the ex-
pression of SOX2, OCT4 and NANOG genes analyzed by
RT-qPCR (Fig. 3). As we expected, the Lenti-Vac trans-
duction does not modified the relative expression of
Fig. 2 HPV16-E2 expression modifies the α6-integrin-CD71 subpopulations profile in HaCaT cell line. a RT-PCR analysis of lentivirus transduced
HaCaT cells 5 days post-infection. HPV16-E2 is expressed only in transduced cells HaCaT-HPV16-E2. b Western blot analysis showing the expression
of HPV16-E2 protein only in the transduced HaCaT-HPV16-E2 cells. c Representative flow cytometry analysis for the α6-integrin-CD71 subpopulations
profile in HaCaT-HPV16-E2 cells. R6 decreases almost 50% while R8 increases at least 5 times in these cells. All images shown are representative of at
least three independent experiments
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SOX2, NANOG or OCT4 in neither of the HaCaT cell
subpopulations; nevertheless, in α6-integrinbri/CD71dim
subpopulation from HaCaT cells expressing HPV16-E2
the mRNA level of SOX2 and NANOG was increased
dramatically (5 and 10 times respectively), compared
with the level observed in the α6-integrinbri/CD71dim
subpopulation in HaCaTwt cells. Interestingly, the ef-
fect of HPV16-E2 on OCT4 expression was in the op-
posite way, since the mRNA levels detected for this
factor in the α6-integrinbri/CD71dim subpopulation
from HaCaT-HPV16-E2 were considerably lower (0.2
times) than the observed in the HaCaTwt α6-
integrinbri/CD71dim subpopulation.
All these changes in the expression of stemness factors
induced by E2 in the α6-integrinbri/CD71dim subpopula-
tion, suggest that this viral protein in HaCaT could be
regulating the fate of the cells either to keeping in a
stemness status or the exit of these “progenitor” cells to
a more differentiated status.
HPV16-E2 protein induces early differentiation in HaCaT
cell line
The increase observed in the α6-integrindim subpopulation
in HaCaT-HPV16-E2 cells, strongly suggest that expres-
sion of the viral protein induces the cells to differentiation.
Then we decided to confirm this, first analyzing the
relative levels of cytokeratin 14, a protein expressed in all
the constituent cells of the epithelial basal layer [50], and
cytokeratin 10, a protein expressed de novo by early differ-
entiated cells [50, 51]. Considering the well known effects
of differentiation induced on HaCaT cells by CaCl2 and
RA treatments, we exposed HaCaTwt cells to either
5 mM CaCl2 or 1 μM RA for 5 days and used as a refer-
ence to compare the expression level of both cytokeratins
in HaCaT-HPV16-E2 cells, by western blot analysis. We
observed in HaCaT-HPV16-E2 cells a considerable lower
level of cytokeratin 14 and more than twice level of
cytokeratin 10, compared to HaCaTwt (Fig. 4, panel a).
This clearly demonstrates that HPV16-E2 protein pro-
motes early differentiation in HaCaT cells. Although
CaCl2 or RA treatments induced in HaCaTwt cells a
decrease in the protein levels of cytokeratins 14 and 10,
the diminution caused by RA was more significant
provoking a reduction of 80% in cytokeratin 14 and
100% in cytokeratin 10 protein levels, while the de-
crease observed with CaCl2 treatment was 10 and 60%
respectively (Fig. 4, panel a). These results indicate that
both treatments induce cell differentiation in a faster
way and probably by a different pathway than HPV16-
E2, since the low level of cytokeratin 10 in exposed cells
suggest they are in a later step in the cell differentiation
process, as has been demonstrated in several reports
[52, 53].
Having in mind that the effects of these differenti-
ation inducers on the α6-integrin-CD71 subpopulations
profile has not been reported, we exposed HaCaT
cultures to either CaCl2 or RA as described above and
analyzed the subpopulations profile obtained by flow cy-
tometry from the α6-integrin-CD71 stained cells. We
observed that both, CaCl2 and RA treatments induced
significant changes in the α6-integrin-CD71 subpopula-
tions profile in HaCaT cell line; however clear differences
between them were observed suggesting that induction of
differentiation with each one of these agents is not equiva-
lent. The main difference observed was that while CaCl2
induced a considerable enrichment in the early differenti-
ated cells (α6-integrindim subpopulation) (32.51 ± 1.15%)
(Fig. 4, panel d), the enrichment induced by RA treatment
in this subpopulation was even higher (66.64 ± 1.5%)
(Fig. 4, panel f).
Considering that cells can naturally receive extracellu-
lar stimulus for differentiation independently of the
HPV16-E2 expression, we exposed HaCaT-HPV16-E2
cells to either, CaCl2 or RA treatments for 5 days and
Fig. 3 HPV16-E2 expression alters the level of stem cell markers in HaCaT cells. RT-qPCR analyses for expression of SOX2, NANOG and OCT4 in
HaCaTwt, HaCaT-Vac and HaCaT-HPV16-E2 total cell population and after sorting in α6-integrinbri/CD71dim and Non-α6-integrinbri/CD71dim
subpopulations. Values are expressed as the difference in ΔΔCt compared to non-infected cells and expression of a housekeeping gene (β-actin).
Relative expression of three separated assays expressed as the mean ± SD, p < 0.05, is presented
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evaluated the subpopulations profile obtained by
flow cytometry from α6-integrin and CD71 stained
cells. Interestingly the subpopulation profile generated
was particular for each differentiation inducer agent
used. In HaCaT-HPV16-E2, CaCl2 treatment induced a
considerable increase in the relative abundance of the α6-
integrinbri/CD71dim subpopulation (0.55 ± 0.06% vs 1.38 ±
0.3%) (Fig. 4, panels c and e [R6]), reaching even higher
amounts than the percentage of cells present in this
subpopulation in HaCaTwt cultures (1.16 ± 0.08%) (Fig. 4,
panel b). Furthermore, this treatment also induced an
increase in the relative abundance of the α6-integrinbri/
CD71bri subpopulation, considered transitory amplifying
cells (45 ± 1.3% vs 68.76 ± 1.12%). This suggests that CaCl2
treatment restricts HPV16-E2 expressing cells to a differ-
entiation state still able to proliferate actively (Fig. 4,
panels c and e [R7]).
By the other side, RA treatment induced in HaCaT-
HPV16-E2 cells an even more marked effect on the differ-
entiation status than on HaCaTwt cells, leading cells
mostly to early differentiation, since the relative abun-
dance of the α6-integrindim subpopulation observed
was a little higher (66.64 ± 1.5% vs 75.84 ± 1.02%)
(Fig. 4, panels f and g [R8]) in HaCaT-HPV16-E2 cells. In
a similar way than the observed in CaCl2 treated HaCaT-
HPV16-E2 cells, RA also increased visibly the relative
abundance of the α6-integrinbri/CD71dim subpopulation,
compared with non-treated HaCaT-HPV16-E2 cells (0.55
± 0.06% vs 0.98 ± 0.39%) (Fig. 4, panels c and g [R6]).
These results suggest that HPV16-E2 protein presence
modifies cellular mechanism inducing the early differen-
tiation of the α6-integrinbri/CD71dim subpopulation in
the HaCaT cell line.
Discussion
HPV infection in the basal epithelial layer may occur in
any cellular type that integrates this layer and then the ex-
pression of the early genes, E2 one of the most important
in this virus, could have particular effects on each one of
the constituent cell types. A limited number of cells in this
epithelial layer, possess cell progenitor characteristics and
this small subpopulation has been identified and isolated
from primary cultures and transformed cell lines by using
different experimental approaches such as detection of
desmoglein-3, α6- and β1-integrins, CD71, the expression
Fig. 4 HPV16-E2 protein promotes differentiation in HaCaT cells in a comparable way than epithelial differentiation inducers. a Western blot
analysis showing the expression of cytokeratin 10 and 14 proteins in non-stimulated HaCaTwt cells, 5 days 5 mM CaCl2 or 1 μM RA stimulated
HaCaTwt cells, and HaCaT-HPV16-E2 cells. Numeric values below each lane are the quantitation results expressed as the ratio to non-stimulated
HaCaTwt cells and normalized against β-actin. Flow - cytometric analysis. Left panels (b, d and f), HaCaTwt cells; right panels (c, e and g), HaCaT-
HPV16-E2 cells. b and c, non-stimulated cells; d and e, CaCl2 stimulated cells; f and g, RA stimulated cells. All images shown are representative of
at least three independent experiments
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and nuclear presence of p63, or the metabolic activity of
ALDH or ABCG transporters in these cells [44–47].
HaCaT cell line that derives from spontaneously im-
mortalized keratinocytes has been widely used to simu-
late epithelial tissues [54, 55]. Using the method
described by Schluter and cols. [48], in this work we
demonstrated for the first time that cultures of the
HaCaT cell line, similarly to the reported in keratino-
cytes primary cultures, contain cellular subpopulations,
based on the identification and simultaneous detection
of the membrane receptors α6-integrin and CD71, corre-
sponding to: early differentiated cells (α6-integrindim),
transitory amplifying cells (α6-integrinbri/CD71bri) and
progenitor cells (α6-integrinbri/CD71dim) (Fig. 1, panel a).
Self-renewal assays, clonogenicity and expression of
the transcription factors NANOG, SOX2 and OCT4 have
been currently used to demonstrate the stemness of
putative progenitor cell populations, no matter the
method used for its isolation, either based on metabolic
characteristics or expression level of specific membrane
proteins [45, 56–58].
The self-renewal capability observed in cells from the
α6-integrinbri/CD71dim subpopulation in HaCaT cells
reported in this work, was similar to that reported in
several works in the identification of both adult normal
and cancer stem cells, where the isolated progenitor
subpopulation was also able to reestablish the initial
phenotype of the total population, increasing also the
number of putative “progenitor” cells after each cycle of
separation [46, 59, 60]. However, in a clear contrast with
cancer stem cells, putative progenitor cell population in
HaCaT was considerably lower and its enrichment after
reseeding was not exponential.
The ability of cells from the α6-integrinbri/CD71dim sub-
population to form in clonogenic assays mostly holoclones
(Fig. 1, panel c), in a similar way than the reported in kera-
tinocytes primary cultures [59], suggest also that cells
from this subpopulation have properties of progenitor epi-
thelial cells.
The presence of mRNA from transcription factors
SOX2, NANOG and OCT4 (Fig. 1, panels d and e),
whose expression has been reported for progenitor cells
in normal keratinocytes [56, 61], only in the α6-
integrinbri/CD71dim subpopulation of HaCaT cells,
largely explains its self-renewal capability and the for-
mation mainly of holoclones. In agreement with our re-
sults, a recent work reported the immunodetection of
NANOG and OCT4 proteins in HaCaT cell line grow-
ing in monolayer conditions, despite in those particular
culture conditions and unlike than the cancer stem
cells evaluated in that work, HaCaT cells were not
capable to form spheroids [45]. Taken together these
results confirm that α6-integrinbri/CD71dim subpopula-
tion that constitutes approximately 1% of the total
population in HaCaT cell line, is enriched in progenitor
cells.
Although HaCaT is an immortalized cell line, it
possesses particular characteristics that make it very
attractive to be used as biological system, such as the
absence of viral sequences in its genome, and its ability
to respond to a variety of differentiation stimuli such as
CaCl2, RA and cell-cell contact [62–64]. Our demonstra-
tion that this cell line possesses, in a low but constant
proportion, a cellular subpopulation that express stem-
ness markers, with self-renewal capability similar to the
observed in normal epithelial stem cells, constitutes an
additional property that must be exploited in this cell
line. Then, HaCaT cell line would seem to be a very
appropriate model to study the effects of viral gene
expression on the three main subpopulations that con-
stitute the epithelial basal layer and that can be target
for the HPV infection.
We observed that expression of HPV16-E2 in HaCaT
cells generated a significant change in the proportion of
the three cellular subpopulations, possibly favoring the
early differentiation, since the relative abundance of pro-
genitor (α6-integrinbri/CD71dim) cells decreased notably,
while cell subpopulation committed to differentiation
(α6-integrinbri) increased (Fig. 2, panel c). These results
confirm and complement the observed by Burns and
cols., whom reported the expression of early differenti-
ation markers in the total population of HaCaT cells
expressing HPV16-E2 [34]. In the same way, previous
reports from our research group in C-33A cells, indi-
cated that the presence of HPV16-E2 modifies the gene
expression profile affecting importantly several signaling
pathways, such as integrins, WNT/β-catenin, RhoA and
Notch [20], all of them relevant for proliferation and cell
differentiation responses.
Although the stem like properties of the HaCaT-
HPV16-E2 cells might not change drastically, some as-
pects of stemness, such as SOX2, NANOG and OCT4
expression are altered. Then, changes in the relative
abundance of the subpopulations could be just another
effect of the expression of HPV16-E2, considering that
our interpretation is based exclusively on the expression
of α6-integrin and CD71. Interestingly the effect on the
expression of the stemness factors is differential, since
while for SOX2 and NANOG the expression is higher in
these cells, the opposite effect is observed for OCT4
(Fig. 3), suggesting that characterization of the E2 cells
may not be so straightforward.
The modification in the expression level of these stem-
ness factors could be related to the ability of HPV16-E2
protein to physically interact with several transcrip-
tion factors such as CBP/p300, SP1, TAF1 and BRD4
[33, 65–68], all of them involved in the regulation of
crucial genes for proliferation and differentiation
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pathways, and also in the regulation of SOX2, NANOG
and OCT4 expression [56, 61]. As an example, it has been
demonstrated that BRD4 is a very important piece in the
regulation of NANOG gene expression [68], and the well
known capability of HPV16-E2 to stabilize the binding of
BRD4 to cellular promoters [69] could explain the overex-
pression observed in cells where HPV16-E2 is present. On
the other side, it has been reported that SP1 factor binds
directly to the OCT4 promoter favoring its transcription
[70]. In this way, the physical interaction of E2 protein
with SP1 [71, 72] could prevent its union to several gene
promoters, OCT4 among them, explaining the low expres-
sion level of this factor observed in our assays.
The changes generated in the expression pattern of the
stemness genes in the progenitor cells in HaCaT-HPV16-
E2, suggest that the viral protein has a similar effect than
the previously described for differentiation inducer agents
[73–76]. Conditions previously reported for stimulation of
differentiation in HaCaT cells with CaCl2 or RA [77, 78],
caused a similar effect on the subpopulations profile to
that observed in HaCaT cells expressing HPV16-E2 (Fig. 4,
panels c, d and f), confirming that this viral protein by
itself is capable to induce a differentiation process. Until
our knowledge, the effect of these differentiation inducers
agents on the cellular subpopulations constituents of this
cell line, has not been reported, then the present work is
pioneering in this respect.
RA treatment of HaCaT-HPV16-E2 cells generated
the apparent acceleration in the differentiation process,
since the majority of cells in the total population corre-
sponded to those committed to early differentiation
(Fig. 4, panel g). However, CaCl2 treatment generated a
profile where almost 70% of the cells corresponded to
the transitory amplifying subpopulation. This means
that in cells expressing HPV16-E2, the stimulus induces
initially an accelerated proliferation process, and then
cell differentiation (Fig. 4, panel e). This behavior could
be explained by an increase in the activity of the cip/
kip family member p21, since it has been demonstrated
that this gene is transcriptionally activated by HPV16-
E2 protein [33, 71, 79], and also by the cascade S100C/
A11 directly induced by CaCl2, leading the cells to
hyperproliferation [77]. The same observed behavior
could be also related to the expression or the absence
of different regulators of the epidermal differentiation,
such as the insulin growth factor binding protein 3
(IGFBP-3), which is characteristically expressed in cells
from the epithelial basal layer and the repression of this
factor by CaCl2 stimulus, leads cells to proliferation
[80]. Interestingly, the effect of either CaCl2 or RA
treatment on the relative abundance of the progenitor
subpopulation in HaCaT-HPV16-E2 cells was radically
different than the observed in HaCaTwt cells, inducing
an increase and reaching 0.98% for RA and 1.38% for
CaCl2 induction (Fig. 4, panels d, e, f and g). This
comportment generated by E2 expression could be due to
both, the direct transcriptional regulation of genes in-
volved in particular pathways, as well as to indirect mech-
anisms at epigenetic level, in genic regions that regulate
cell fate decision to stemness or to differentiation.
Taken together these results suggest that the synergy
between the differentiation stimulus that represents the
expression of HPV16-E2 accompanied of a second dif-
ferentiation stimulus such as CaCl2 or RA (HPV16-E2/
CaCl2 and HPV16-E2/AR) can promote the exit of
some of the “progenitor cells” to the next immediate
higher differentiation level, while the remaining percent-
age of this subpopulation is apparently less receptive to
the stimulus, giving to these cells the opportunity to stays
in a stemness status. These effects could guarantee the
continuation of the replicative cycle that depends of
the epithelial differentiation, besides the preservation of
a small amount of progenitor cells ensuring the viral
persistence.
Conclusions
In summary, we determined that HaCaT cell line possess
three subpopulations that correspond to early differenti-
ated, transitory amplifying and early progenitor cells. This
latter population fully accomplishes the stem-like charac-
teristics, such as enrichment, self-renewal, regeneration of
the total population and expression of the stemness
factors NANOG, SOX2 and OCT4. The HPV16-E2 ex-
pression modifies the relative abundance of the subpopu-
lations, and affects the expression of the stemness factors.
These changes could be involved in the control of the exit
from stemness to transitory amplified cells or early differ-
entiated cells. Further research on the effects of HPV16-
E2 expression and the differentiation pathways it regulates
is needed.
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